Success for pharma companies in the modern world of healthcare is about far more than getting good drugs to market. It’s also about getting word out about products, widening access to them, then proving their efficacy.
These are significant challenges in a fragmented healthcare system beset by drug-access problems, poor prescription adherence, data silos and myriad social and economic issues.
But an exciting new pharma business model is emerging that will encourage a network of payers and providers to align around pharma industry products and harness large sets of data to drive better drug access, drug adherence and visibility of patient care.
We call it Networked Health. It’s a pharma business model that has the potential to create a new health ecosystem that transforms patient outcomes – with your products at the center.